Nov 20, 2019
Antimicrobial resistance (AMR) is a global threat. As per the UN estimates, the global trends reveal that each year 7,00,000 people die due to drug-resistance. Moreover, around 230,000 people die due to multidrug-resistant tuberculosis. The trends in the US depicted an equally disheartening. A report titled...
Read More...
Jul 24, 2019
Antibiotics are amazing. Right? There was a time when thousands of people lost their lives due to some severe bacterial diseases. However, thanks to the British scientist Alexander Fleming, now many life-threatening diseases can be cured using Antibiotics when given at the right time. With the success of penicillin...
Read More...
Aug 23, 2018
AstraZeneca dragout Entasis files to fund antibiotic phase 3 for USD 86 Million IPO Massachusetts-based Entasis Therapeutics has spun out to raise up to USD 86 Million through an IPO. The AstraZeneca spinout is attempting to fund a phase 3 trial of a drug to overcome bacterial resistance to beta-lactams. In 2015, ...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper